(S)-2-Amino-3-(pyridazin-3-yl)propanoic acid hydrochloride, 95.0%, 25mg

N-Ethylnicotinamide, 98%, 5g

3-Bromophenacyl bromide, 98.0%, 25g

2-Methoxy-4-methylnicotinonitrile, 95.0%, 250mg

1,3,3-Trimethyl-6'-(piperidin-1-yl)spiro[indoline-2,3'-naphtho[2,1-b][1,4]oxazine], 97%, 5g

4-(Trifluoromethylthio)benzoyl chloride, 95.0%, 5g

(E)-1-(4-(trifluoromethoxy)phenyl)ethanone oxime, 97%, 5g

2-Oxo-2-(1-pyrrolidinyl)ethanamine, 95.0%, 1g

ZEAXANTHIN, 85%, 50mg

(E)-Methyl 3-(4-cyano-3-methoxyphenyl)acrylate, 10g

Methyl 3-fluoropyridine-2-carboxylate, 95.0%, 25g

Infinity corrected plan phase S40x/0.65 objective. Working distance 0.36 mm

(2-AMINO-3-FLUOROPHENYL)METHANOL, 95.0%, 1g